Kliemank E - Search Results

1

Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study.

Sulaj A, Kopf S, von Rauchhaupt E, Kliemank E, Brune M, Kender Z, Bartl H, Cortizo FG, Klepac K, Han Z, Kumar V, Longo V, Teleman A, Okun JG, Morgenstern J, Fleming T, Szendroedi J, Herzig S, Nawroth PP. Sulaj A, et al. Among authors: kliemank e. J Clin Endocrinol Metab. 2022 Jul 14;107(8):2167-2181. doi: 10.1210/clinem/dgac197. J Clin Endocrinol Metab. 2022. PMID: 35661214 Free PMC article. Clinical Trial.

2

Group Singing as a Therapy during Diabetes Training--A Randomized Controlled Pilot Study.

Groener JB, Neus I, Kopf S, Hartmann M, Schanz J, Kliemank E, Wetekam B, Kihm L, Fleming T, Herzog W, Nawroth PP. Groener JB, et al. Among authors: kliemank e. Exp Clin Endocrinol Diabetes. 2015 Nov;123(10):617-21. doi: 10.1055/s-0035-1555941. Epub 2015 Aug 4. Exp Clin Endocrinol Diabetes. 2015. PMID: 26240957 Clinical Trial.

3

Michaelis-Menten Kinetics Measurements of Aldo-Keto Reductases for Various Substrates in Murine Tissue.

Morgenstern J, Kliemank E, Campos MC, Nawroth P, Fleming T. Morgenstern J, et al. Among authors: kliemank e. STAR Protoc. 2020 Dec 7;1(3):100206. doi: 10.1016/j.xpro.2020.100206. eCollection 2020 Dec 18. STAR Protoc. 2020. PMID: 33377100 Free PMC article.

4

Quantification of All-Trans Retinoic Acid by Liquid Chromatography-Tandem Mass Spectrometry and Association with Lipid Profile in Patients with Type 2 Diabetes.

Morgenstern J, Fleming T, Kliemank E, Brune M, Nawroth P, Fischer A. Morgenstern J, et al. Among authors: kliemank e. Metabolites. 2021 Jan 19;11(1):60. doi: 10.3390/metabo11010060. Metabolites. 2021. PMID: 33478094 Free PMC article.

5

Verification of sex- and age-specific reference intervals for 13 serum steroids determined by mass spectrometry: evaluation of an indirect statistical approach.

Anker SC, Morgenstern J, Adler J, Brune M, Brings S, Fleming T, Kliemank E, Zorn M, Fischer A, Szendroedi J, Kihm L, Zemva J. Anker SC, et al. Among authors: kliemank e. Clin Chem Lab Med. 2022 Dec 20;61(3):452-463. doi: 10.1515/cclm-2022-0603. Print 2023 Feb 23. Clin Chem Lab Med. 2022. PMID: 36537103

6

Impact of the -1T>C single-nucleotide polymorphism of the CD40 gene on the development of endothelial dysfunction in a pro-diabetic microenvironment.

Joshi P, Mohr F, Rumig C, Kliemank E, Krenning G, Kopf S, Hecker M, Wagner AH. Joshi P, et al. Among authors: kliemank e. Atherosclerosis. 2023 Nov 14:117386. doi: 10.1016/j.atherosclerosis.2023.117386. Online ahead of print. Atherosclerosis. 2023. PMID: 38030458 Free article.

7

Accumulation of Non-Pathological Liver Fat Is Associated with the Loss of Glyoxalase I Activity in Humans.

Peter A, Schleicher E, Kliemank E, Szendroedi J, Königsrainer A, Häring HU, Nawroth PP, Fleming T. Peter A, et al. Among authors: kliemank e. Metabolites. 2024 Apr 7;14(4):209. doi: 10.3390/metabo14040209. Metabolites. 2024. PMID: 38668337 Free PMC article.

8

Non-cross-linking advanced glycation end products affect prohormone processing.

Brings S, Mier W, Beijer B, Kliemank E, Herzig S, Szendroedi J, Nawroth PP, Fleming T. Brings S, et al. Among authors: kliemank e. Biochem J. 2024 Jan 10;481(1):33-44. doi: 10.1042/BCJ20230321. Biochem J. 2024. PMID: 38112318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page